Burkitt lymphoma risk in U.S. solid organ transplant recipients
Open Access
- 27 December 2012
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 88 (4) , 245-250
Abstract
Case reports of Burkitt lymphoma (BL) in transplant recipients suggest that the risk is markedly elevated. Therefore, we investigated the incidence of BL in 203,557 solid organ recipients in the U.S. Transplant Cancer Match Study (1987–2009) and compared it with the general population using standardized incidence ratios. We also assessed associations with demographic and clinical characteristics, and treatments used to induce therapeutic immunosuppression. BL incidence was 10.8 per 100,000 person‐years, representing 23‐fold (95% confidence interval (CI) 19–28) greater risk than in the general population, and it peaked 3–8 years after the time of transplantation. In adjusted analyses, BL incidence was higher in recipients transplanted when <18 vs. ≥35 years (incidence rate ratio [IRR] 3.49, 95% CI 2.08–5.68) and in those transplanted with a liver (IRR 2.91, 95% CI 1.68–5.09) or heart (IRR 2.39, 95% CI 1.30–4.31) compared with kidney. BL incidence was lower in females than males (IRR 0.45, 95% CI 0.28–0.71), in blacks than whites (IRR 0.33, 95% CI 0.12–0.74), in those with a baseline Epstein‐Barr virus (EBV)‐seropositive versus EBV‐seronegative status (IRR 0.34, 95% CI 0.13–0.93), and in those treated with azathioprine (IRR 0.56, 95% CI 0.34–0.89) or corticosteroids (IRR 0.48, 95% CI 0.29–0.82). Tumors were EBV‐positive in 69% of 32 cases with results. EBV positivity was 90% in those aged <18 years and 59% in those aged 18+ years. In conclusion, BL risk is markedly elevated in transplant recipients, and it is associated with certain demographic and clinical features. EBV was positive in most but not all BL cases with results. Am. J. Hematol. 88:245–250, 2013.Keywords
This publication has 29 references indexed in Scilit:
- Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genesBlood, 2012
- Antibodies against malaria and Epstein‐Barr virus in childhood Burkitt lymphoma: A case‐control study in UgandaInternational Journal of Cancer, 2007
- Kaposi's sarcoma risk among transplant recipients in the United States (1993–2003)International Journal of Cancer, 2006
- Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomasBlood, 2005
- Secondary neoplasms as a consequence of transplantation and cancer therapy.1988
- Non-Hodgkin's Lymphoma in 90 Homosexual MenNew England Journal of Medicine, 1984
- Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and menCell, 1983
- The American Burkitt's lymphoma registry:Eight years' experienceCancer, 1982
- A Children's Cancer Dependent on Climatic FactorsNature, 1962
- A sarcoma involving the jaws in african childrenBritish Journal of Surgery, 1958